Long term management of bronchopulmonary dysplasia

Chairs: Liesbeth Duijts et Marielle Pijnenburg

Bronchopulmonary dysplasia (BPD) isachroniclungdisease thatmostcommonly occurs after preterm birth.Theincidence ofBPD hasnot declined over the pastdecade butthe severity and the clinical course of BPD have┬Ěchanged with current advanced neonatal practice, leading to a new form of BPD.

Children with BPD have an increased risk of persisting or even progressing impaired lung structure, lower function, respiratory symptoms and related diseases such as pulmonary hypertension, and hospital admissions in infancy but also in later life. Infuture, children with BPD may form a new group of chronic obstructive pulmonary disease (COPD) in adulthood.

Several monitoring tools and treatment possibilities after the neo natal period for children with BPD have been proposed. However, clear recommendations on how to monitor and treat children with established BPD to prevent orminimize adverse effects at the long-term are lacking and urgently needed.The aims of this task force are to:

  1. review the evidence for a vailable monitoring tools
  2. review the evidence for different treatment options
  3. provide recommendations on minimal, optimal and ideal structured, multi-disciplinary follow-up programs and treatment for children with BPD after the neonatal period.